[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552223":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":39,"centralContacts":43,"locations":52,"responsibleParty":69,"collaborators":33,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":33,"eligibilityCriteria":78,"healthyVolunteers":79,"sex":80,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":33,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":54,"whyStopped":33,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"University of Cincinnati","OTHER",[8,14,20,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Healthy Control- Saline","PLACEBO_COMPARATOR","Saline will be infused in healthy control subjects during insulin-induced hypoglycemia",[13],"Other: Saline",{"label":15,"type":16,"description":17,"interventionNames":18},"Healthy Control- C-peptide","ACTIVE_COMPARATOR","C-peptide will be infused in healthy control subjects during insulin-induced hypoglycemia",[19],"Biological: C-peptide",{"label":21,"type":10,"description":22,"interventionNames":23},"T1D- Saline","Saline will be infused in T1D subjects during insulin-induced hypoglycemia",[13],{"label":25,"type":16,"description":26,"interventionNames":27},"T1D- C-peptide","C-peptide will be infused in T1D subjects during insulin-induced hypoglycemia",[19],[29,34],{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Saline","Normal saline will be infused during insulin-induced hypoglycemia",[9,21],null,{"type":35,"name":36,"description":37,"armGroupLabels":38,"otherNames":33},"BIOLOGICAL","C-peptide","C-peptide will be infused during insulin-induced hypoglycemia",[15,25],[40],{"name":41,"affiliation":5,"role":42},"Jason Winnick, PhD","PRINCIPAL_INVESTIGATOR",[44,48],{"name":41,"role":45,"phone":46,"phoneExt":33,"email":47},"CONTACT","513-558-4437","jason.winnick@uc.edu",{"name":49,"role":45,"phone":50,"phoneExt":33,"email":51},"Natalie Whitsett","513-558-4489","whitsenh@ucmail.uc.edu",[53],{"facility":5,"status":54,"city":55,"state":56,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"RECRUITING","Cincinnati","Ohio","45267-0547","United States","US",{"type":61,"coordinates":62},"Point",[63,64],-84.51439,39.12711,{"lat":64,"lon":63},[67,68],{"name":41,"role":45,"phone":46,"phoneExt":33,"email":47},{"name":49,"role":45,"phone":33,"phoneExt":33,"email":51},{"type":42,"investigatorFullName":70,"investigatorTitle":71,"investigatorAffiliation":5,"oldNameTitle":33,"oldOrganization":33},"Jason Winnick","Principal Investigator","100552223","early-phase-1-effect-of-c-peptide-on-hypoglycemic-counterregulation-100552223",false,"NCT06470295","Effect of C-peptide on Hypoglycemic Counterregulation","On the Regulation of Hepatic Glucose Metabolism During Insulin-induced Hypoglycemia","Inclusion Criteria:\n\n* BMI less than 30 kg\u002Fm2\n\nExclusion Criteria:\n\n* pregnant or lactating women cigarette smoking presence of HIV or hepatitis presence of cardiovascular disease presence of microvascular disease",true,"ALL","18 Years","40 Years",{"count":84,"type":85},38,"ESTIMATED","INTERVENTIONAL",[88],"EARLY_PHASE1","Iatrogenic hypoglycemia is the most prominent barrier to the safe, effective management of blood sugar in people with type 1 diabetes due to periodic over-insulinization. During insulin-induced hypoglycemia, glucagon secretion is diminished in type 1 diabetes which, in turn, reduces hepatic glucose production and increases the depth and duration of hypoglycemic episodes. We have observed that the naturally occurring protein C-peptide increases glucagon secretion in dogs during insulin-induced hypoglycemia, which increases hepatic glucose production; the experiments in this application will shed light on the translation of this finding to the human.",[91,92],"Hypoglycemia","Type 1 Diabetes",[94,95,36],"glucagon","hepatic glucose production","2026-02-13",{"date":98,"type":99},"2026-02-17","ACTUAL",{"date":101,"type":99},"2024-06-01",{"date":103,"type":85},"2028-01-01",{"name":5,"class":6},1]